本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Olema Pharmaceuticals, Inc.

5.16
+0.12002.38%
成交量:70.72万
成交额:363.30万
市值:3.53亿
市盈率:-2.34
高:5.25
开:4.98
低:4.95
收:5.04
数据加载中...
2025/03/19

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/19

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/19

重要事件披露

Form 8-K - Current report
2025/03/05

重要事件披露

Form 8-K - Current report
2025/01/13

SEC问询函

Form CORRESP - Correspondence
2025/01/13

SEC问询函

Form CORRESP - Correspondence
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/10

重要事件披露

Form 8-K - Current report
2024/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/11

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities